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OBJECTIVE: To evaluate the effect of blocking the angiotensin II AT-1 receptor by the systemic administration
of candesartan on the expression of intercellular adhesion molecule-1 in the sclera and choroid of
hypercholesterolemic rabbits.
METHODS: New Zealand rabbits were divided into 3 groups, as follows: GI, which was fed a rabbit standard
diet; GII, which was fed a hypercholesterolemic diet; and GIII, which received hypercholesterolemic diet plus
candesartan. Samples of the rabbits’ sclera and choroid were then studied by hematoxylin-eosin staining and
histomorphometric and immunohistochemical analyses for intercellular adhesion molecule-1 expression.
RESULTS: Histological analysis of hematoxylin- and eosin-stained sclera and choroid revealed that macrophages
were rarely present in GI, and GII had significantly increased macrophage numbers compared to GIII. Moreover,
in GII, the sclera and choroid morphometry showed a significant increase in thickness in comparison to GI and
GIII. GIII presented a significant increase in thickness in relation to GI. Sclera and choroid immunohistochemical
analysis for intercellular adhesion molecule-1 expression revealed a significant increase in immunoreactivity in
GII in relation to GI and GIII. GIII showed a significant increase in immunoreactivity in relation to GI.
CONCLUSION: Candesartan reduced the expression of intercellular adhesion molecule-1 and consequently
macrophage accumulation in the sclera and choroid of hypercholesterolemic rabbits.
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& INTRODUCTION
Macrophages are the dominant cellular players in chronic
inflammation and secrete cytokines, enzymes and growth
factors that contribute to the development and progression
of several pathologies. Thus, macrophages have become a
very important therapeutic target. There is evidence that
age-related macular degeneration (ARMD) and athero-
sclerosis share similar physiopathogenic mechanisms (1,2).
ARMD is the main cause of irreversible blindness in older
people and may lead to a loss of central vision due to
choroid geographic atrophy or the formation of sub-retinal
neovascularization. The cardiovascular complications, sec-
ondary to the atherosclerotic process, and the blindness
induced by ARMD result in increased macrophage accu-
mulations in the arterial wall and in the Bruch’s membrane,
respectively (3,4).
Intercellular Adhesion Molecule 1 (ICAM-1), also known
as CD54, is a glycoprotein of the immunoglobulin super
family. Similar to other adhesion molecules, ICAM-1 is
distributed on endothelial cells and leukocytes and induces
the recruitment of leukocytes to lesioned or inflamed tissues
(5). In the human ocular globe, a greater concentration of
this immunoglobulin has been found in the choriocapillaris
of the macular region than in the peripheral region (6). This
finding suggests that many immune cells, including macro-
phages, may be present in the macula. This finding also
accounts for the greater formation of the subretinal
neovascular membrane (wet ARMD) in this region.
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In atherosclerosis, macrophages decrease atherosclerotic
plaque formation (7). In ARMD, experimental studies have
shown that the inhibition of macrophage functions
improves the neovascular condition (8). Thus, drugs that
inhibit the mobilization and/or adhesion of monocytes to
the inflamed tissue may be effective not only for treating
atherosclerosis, but also for preventing the development of
ARMD. Additionally, previous studies have suggested that
the activation of the renin-angiotensin system is related to
the physiopathogenesis of ARMD and that the blockade of
this system is related to its regression (9,10).
The objective of this study was to determine the effects of
candesartan-mediated blockage of the angiotensin II AT-1
receptor on ICAM-1 expression and the accumulation of
macrophages in the sclera and choroid of hypercholester-
olemic rabbits.
& MATERIALS AND METHODS
Experimentation environment
The procedures described in this study were performed at
the Surgical Technique Laboratory at Pontificia Universidade
Cato´lica do Parana´, Graduation, Curirtiba/PR (PUC-PR) and
the Study Center of the Angelina Caron Hospital. The
animals were kept in an animal facility (macroenvironment)
on 12/12-hour light cycles, with air changes and room
temperature controlled between 19 and 23 C˚. During the
experimental period, the animals were fed water and
standard NuvitalH rabbit chow (Nuvital, Colombo, Brazil)
ad libitum.
Animals used and experiment design
In total, 33 white adult male rabbits (New Zealand) with a
mean age of 3.6 months were selected for this study. The
animals were divided into three groups as follows: Group I
(GI), normal diet group, 8 rabbits; Group II (GII), hyperch-
olesterolemic diet group, 13 rabbits; and Group III,
candesartan-treated hypercholesterolemic group, 12 rabbits.
During the 56-day study, the animals in GII and GIII were
fed a specific diet, NuvitalH Lab (Nuvital, Colombo, Brazil)
plus 1% cholesterol (Sigma-AldrichH). The daily amount of
food per animal was 600 grams (11). The diet, NuvitalH Lab
(Nuvital, Colombo, Brazil), does not alter lipid metabolism
in the animals. For the GIII group, 2.62 mg/kg/day
of candesartan cilexetil (AstraZeneca, London, United
Kingdom) was administered by oral gavage from day 1
through day 56. On day 56, the animals from GII and GIII
were euthanized. Animals from GI were fed only NuvitalH
Lab chow and were euthanized on day 28. Serum levels of
total cholesterol, triglycerides and glucose were determined
in fasting rabbits at the beginning of the experiment and the
time of euthanasia. Euthanasia was performed by intrave-
nous anesthesia with 5 ml pentobarbital, and the rabbit eyes
were immediately placed in 4% paraformaldehyde (Merck,
Darmstadt, Germany) in 0.1 M phosphate, pH 7.4, for
4 hours. The eyes were then used for the morphometrical
and immunohistochemical analyses of the choroid-sclera
complex.
Tissue preparation
After fixation, the samples were evaluated macroscopi-
cally. A coronal section was performed at the level of the
optic nerve, and the ocular globe was divided into two
equal halves. The lower half was stored for future study,
and the upper half was dehydrated, diaphanized and
embedded in paraffin using a LeicaH TP 1020 – Automatic
Tissue Processor (Leica, Wetzlar, Germany). A LeicaH
EG1160 paraffin-embedding device was used to produce
the paraffin blocks. A LeicaH RM2145 Microtome was used
to obtain 5-mm-thick sections for histology. The sections
were placed on glass slides smeared with albumin, stained
with hematoxylin-eosin and mounted with 24 6 900-mm
coverslips using Entellan Mounting Media (Merck,
Darmstadt, Germany).
Scleral and choroid histomorphometry
For quantitative analysis, the evaluated sections were
stained with hematoxylin-eosin. With the aid of a 4x
objective lens and a blue overhead projector marker, the
hemi-sectioned ocular globe was divided manually into 10
equal segments from the pars plana to the contralateral pars
plana. Segment images were obtained (10 images of each
eye) using an Olympus BX50 microscope (Olympus, Tokyo,
Japan) connected to a Sony BX50 camera (Sony Corporation,
Tokyo, Japan). In each captured image, four linear morpho-
metric measurements were taken using the Image ProplusH
software supplied with the BX50 (Media Cybernetics Inc.,
Silver Spring, MD). Accordingly, 40 measurements were
taken from each eye to evaluate choroidal and scleral
thicknesses. Finally, the mean of the four measurements of
each of the 10 segments was obtained. The results are
expressed in micrometers.
Tissue preparation and immunohistochemical
analysis
The histological slices were first blocked against endogen-
ous peroxidase. They were then washed in deionized water
and incubated in a moist chamber at 95 C˚ for 20 minutes for
antigen retrieval, after which the endogenous peroxidase was
blocked again. Primary mouse anti-ICAM-1 monoclonal
antibody (15100, Novocastra, Newcastle upon Tyne, UK)
was then added to the slides. Next, the slices were incubated
with a secondary antibody, EnvisionH System labeled
polymer-HRP anti-mouse (DakoCytomation, Carpinteria,
CA, USA), at room temperature for 30 min. The slices were
then stained by incubation with freshly prepared DAB
substrate (DakoCytomation, Carpinteria, CA, USA) for 3 to
5 minutes. Finally, the slides were counterstained with Mayer
hematoxylin and mounted.
Positive and negative controls were used in all evalua-
tions, and a masked observer initially analyzed the slides. In
this analysis, positive and negative results for the marker
detected by anti-ICAM-1 were recorded. The positive areas,
which were a brownish color, were studied utilizing color
morphometry. This procedure was performed by capturing
images of three consecutive fields that were close to the
optic nerve head with a BX50 Olympus microscope
(Olympus, Tokyo, Japan) coupled to a Sony camera (Sony
Corporation, Tokyo, Japan), Model DXC-107A, using a 40x
objective. The computer program, Image Pro Plus, enabled
the observer to select and color the positive areas and
automatically determined the immunoreactive area in
square micrometers. The data obtained were compiled in a
Microsoft Excel spreadsheet (Redmond, WA) for statistical
analysis. The immunoreactive area represents the sum of all
positive areas in each of the three fields studied. This color
morphometry method was previously used in other studies
(12).
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To compare the defined groups for treatment in relation
to the quantitative variables, one-way analysis of variances
(ANOVA) was performed. Multiple comparisons were
made using the LSD (least significant difference) test. The
baseline and euthanasia time evaluations within each group
were analyzed using Student’s t-test for paired samples.
Normality was assessed with the Shapiro-Wilk test.
Logarithmic transformation was performed for variables
showing skewed data. Values of p,0.05 indicated statistical
significance. Statistica 8.0 (StatSoft. Inc. 2300 East 14th Street
Tulsa, Oklahoma, USA) was used for data processing.
Ethics
Animals were handled in compliance with the principles
established by the Association for Research in Vision and
Ophthalmology (ARVO), and the protocol was approved by




At baseline, there were no significant differences in the
laboratory variables of the animals, both within the same group
and between groups. Additionally, the rabbits did not show
significant alterations in their glycemic values at the time of
euthanasia. Conversely, at the time of euthanasia, total
cholesterol, which was approximately 42 mg/dl at baseline,
reached 2200.00 mg/dl in GII and 923.6 mg/dl in GIII. These
increases were significant compared to GI. Triglyceride was
approximately 53 mg/dl at baseline; at the end of the
experiment, it increased to 168 mg/dl in GII and 171 mg/dl
in GIII, which was a significant increase compared to GI.
Sclera and choroid analysis with hematoxylin-eosin
The sclera and choroids obtained from animals in GI
had very few histiocytes (Figure 1.1). Conversely, a large
number of histiocytes were observed in the sclera-choroidal
complex from GII animals (Figure, 1.2). The sclera-choroidal
complexes from GIII animals (Figure 1.3) had fewer
histiocytes than GII, but more than GI.
Sclera and choroid morphometric analysis
A significant increase in the thickness of the sclera and
choroid was observed in GII compared to GI and GIII
(p,0.001). The thickness in GIII was significantly higher
compared to GI (p= 0.008).
The differences in thickness of the sclera-choroidal
complexes among the groups are shown in Figure 1.
Table 1 shows the thicknesses of the sclera and choroid of
the three groups in micrometers.
Immunoreactivity to ICAM-1
The hypercholesterolemic group (GII) exhibited a sig-
nificant increase in immunoreactivity to ICAM-1 compared
to GI and GIII (p,0.001). Immunoreactivity was also
significantly increased in GIII in relation to GI (p= 0.041).
Table 2 shows the values of the areas immunoreactive to
ICAM-1 antibody in square micrometers, as determined by
the color morphometry technique.
In GI animals, the choroid-sclera complex was predomi-
nantly stained blue, revealing a low level of ICAM-1
immunoreactivity (Figure 2.1). Conversely, in GII animals,
the choroid-sclera complex was predominantly orange,
revealing a high level of immunoreactivity (Figure 2.2).
Figure 2.3, which represents the GIII choroid-sclera complex,
shows that the ICAM-1 immunoreactivity level in GIII was
higher than in GI (Figure 2.1) and lower than in GII (Figure 2.2).
& DISCUSSION
In this study, rabbits were fed a cholesterol-enriched diet,
and the effects of candesartan on ICAM-1 expression and
macrophage accumulation in the sclera and choroid were
assessed. As has been demonstrated in the cardiovascular
system (3,13), dyslipidemia caused significant increases in
ICAM-1 expression in the sclera and choroid in GII and GIII
animals (Table 2). The role of immunoglobulins in the
formation of atheromatous plaques in the great vessels is
well defined. ICAM-1 induces the adhesion of the circulat-
ing monocytes to the vascular endothelium. Once in the
arterial wall intima, these cells are transformed into
macrophages, which contribute to the formation of athero-
sclerotic plaque (3,13). In the normal eye, ICAM-1 immu-
noglobulin is expressed at low levels in the choroid and
retina vascular endothelium, retinal pigment epithelium
(EPR), Bruch’s membrane and external limiting membrane
(14-16). However, in pathological conditions, such as in
exudative ARMD, a significant increase in ICAM-1 expres-
sion has been observed in the EPR cells and choroidal
Figure 1 - C- Choroid; S- Sclera; H- Histiocytes. Figure 1 shows the
sclera and choroid from the GI group. They were of normal
thickness, with very few histiocytes. Figure 2 shows the sclera and
choroid from the GII group. They were of increased thickness,
which was mainly due to the high number of histiocytes. Figure 3
shows the sclera and choroid from the GIII group. There were
fewer histiocytes in GIII than in GII, and the thickness of the
sclera and choroid were higher than in GI and lower than in GII.
Table 1 - Sclera and choroid thicknesses in micrometers.
Variable Group n Mean Median Min Max Standard Deviation p-value*
Choroid and Sclera Morphometry GI 8 232.9 221.4 192.9 307.7 35.8
GII 13 382.5 387.9 254.0 475.0 60.5
GIII 12 284.8 278.5 240.0 390.5 43.4 ,0.001
*ANOVA, p,0.05.
GI vs. GII: p,0.001; GI vs. GIII: p=0.008; GII vs. GIII: p,0.001.
GI - Normal diet group; GII - Cholesterol-enriched diet group; GIII - Cholesterol-enriched diet plus candesartan diet group.
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vessels (9,17-18). Due to the role of ICAM-1 in regulating
leucocyte adherence (5), the increased expression of this
immunoglobulin may account for the increase in macro-
phages and, consequently, the increased thickness of the
sclera-choroid complex (Table 1), which was observed here
and previously in other studies (12,19).
In this study, by inducing hypercholesterolemia, we
attempted to create a physiopathogenic condition that is
similar to ARMD, in which the accumulation of oxidized
lipids attracts macrophages, which can clear the oxidized
lipids (4,20). Besides producing vascular endothelial growth
factor (VEGF), macrophages are also sources of pro-
inflammatory and pro-angiogenic cytokines, such as inter-
leukin (IL)-6 and tumor necrosis factor (TNF), which
mediate inflammatory responses and contribute to the
formation of the sub-retinal neovascular membrane (21-
25). It is important to note that oxidized low-density
lipoprotein (LDL) is a powerful stimulus that increases the
expression of chemotactic and adhesion molecules, which
then attracts macrophages to the inflammatory tissue. This
process occurs in both atherosclerosis and ARMD (4,20). It is
also known that not only the oxidized but also the native
LDL induces the increase in the ICAM-1 expression (26).
Hence, LDL, which is deposited on the Bruch’s membrane,
formed by the degradation of photoreceptor outer segments
(20,27), can increase the expression of these adhesion
molecules, a determinant aspect in the increase of macro-
phages and development of AMRD.
As AMRD and atherosclerosis present similar physio-
pathogenic mechanisms (1,2,3,13), it is expected that the
drugs used to treat these diseases will have equivalent
characteristics and performances. Candesartan blocks the
angiotensin II AT-1 receptor, thereby preventing angioten-
sin-mediated effects. It is important to note that angiotensin
II induces the increased expression of cytokines (IL-6, IL-1,
TNF-a), chemokines (monocyte chemotactic protein-1 –
MCP-1) and leucocyte adhesion molecules (selectins P, E
and L; integrins a1 and b2; VCAM; ICAM) (28,29).
Moreover, among all of the renin-angiotensin system
(RAS) blockers, candesartan is considered to have the
strongest affinity to the AT-1 receptor. This class of drug
is widely used to treat arterial hypertension and has been
shown to reduce the levels of soluble ICAM-1 in hyperch-
olesterolemic patients (30). Experiments have demonstrated
that the blockade of AT-1 receptors of the RAS reduces the
numbers of macrophages, monocytes and T lymphocytes in
atheromatous plaques (7). In the present study, the use of
candesartan to block the angiotensin II AT-1 receptor (GIII)
significantly reduced the expression of ICAM-1 in the sclera
and choroid compared to GII (p,0.001) (Table 2), which
may have reduced the thickness of the GIII sclera-choroid
complex in relation to GII (p,0.001) (Table 1).
In a recent study, our group showed that olmesartan
reduced the expression of MCP-1 and the accumulation of
macrophages in the sclera and choroid of hypercholester-
olemic rabbits (31). Besides blocking the binding of
angiotensin II to the AT1 receptors, olmesartan exerts a
mild modulatory activity on PPAR-gamma receptors (32).
Thus, the olmesartan-mediated decrease of macrophages in
the sclera-choroid complex could also be accounted for by
the drug’s agonistic effect on the PPAR-gamma receptors
(12). In the present study, the RAS blockade was induced by
candesartan, which does not exert this agonistic effect on
PPAR-gamma receptors. This finding shows that RAS
blockade alone can decrease the accumulation of macro-
phages in the sclera-choroid complex, as occurs in the great
vessels (33).
It has been demonstrated that the blockade of the
angiotensin II AT-1 receptor reduces the presence of
macrophages and the expression of inflammatory markers
in the RPE and choroid, thus significantly affecting the
formation of the sub-retinal neovascular membrane
(9,10,34). Hence, by playing an important role in the
pathological processes of angiogenesis and inflammation
(35), the angiotensin II AT-1 receptor may represent a new
target for the treatment of ARMD.
In this study, we used immunohistochemistry to
analyze the sclera and choroid of hypercholesterolemic
rabbits. Immunohistochemistry, when used on paraffin-
embedded material, enables the researcher to locate and
identify proteins in the analyzed tissues. The authors
acknowledge that while the Western blot technique offers
high sensitivity for detection and would improve the
analysis of the studied protein, it usually requires fresh or
frozen tissues. As the ocular globes were fixed in
paraformaldehyde and then embedded in paraffin, it
was not possible to complement the study with the
Western blot technique.
Table 2 - Area showing immunoreactivity to ICAM-1 antibody, in square micrometers, obtained from the color
morphometry analysis.
Variable Group n Mean Median Min Max Standard Deviation p-value*
Area immunoreactive to ICAM-1 GI 8 607.0 218.5 50.2 2200.4 858.7
GII 13 3600.2 3288.7 1867.7 6368.8 1377.3
GIII 12 1231.3 1267.6 119.9 3048.4 951.3 ,0.001
*Nonparametric Kruskal-Wallis test, p,0.05.
GI vs. GII: p,0.001; GI vs. GIII: p=0.041; GII vs. GIII: p,0.001.
GI - Normal diet group; GII - Cholesterol-enriched diet group; GIII - Cholesterol-enriched diet plus candesartan diet group.
Figure 2 - C- Choroid; S- Sclera. 1) GI sclera and choroid. The
prevalence of the bluish color demonstrates the low levels of
immunoreactivity to ICAM-1. 2) GII sclera and choroid. The
prevalence of the orange color demonstrates the high levels of
immunoreactivity to ICAM-1. 3) GIII sclera and choroid. The
orange areas indicate immunoreactivity to ICAM-1. Specifically,
this reactivity was higher than in GI and lower than in GII.
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